US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

10  11  12  13    15    17  18  19  
DNA Gene Chip Trends
1/1/2014 | published by: Global Industry Analysts
... their ability to speed up the process of research. The primary research applications include geneID, comparative genomic hybridization, profiling of gene expression as well as re-sequencing and genotyping in human, plant, prokaryotes and eukaryotes genomes. ...  |  read more...
$950.00
Gene Expression Reagent Trends
1/1/2014 | published by: Global Industry Analysts
... including unicellular as well as multicellular organisms, primarily for generating their macromolecular machinery. The report analyzes and presents an overview of Gene Expression Reagents market worldwide. Supported with 3 market data tables, the report provides ...  |  read more...
$950.00
In Vitro Toxicity Testing: Technologies and Global Markets
1/1/2014 | published by: BCC Research
... reach nearly $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017. This report provides: An overview of the global in vitro toxicity testing market, ...  |  read more...
$6,650.00
Virus-Like Particles (VLPs) Trends
1/1/2014 | published by: Global Industry Analysts
... the absence of viral genetic material. While lacking the DNA material, VLPs retain key immunological characteristics of viruses including particulate structures; repetitive surfaces; and capability to induce innate immunity by activating molecular-pattern pathogen-associated recognition receptors." ...  |  read more...
$950.00
Biomimetics Trends
1/1/2014 | published by: Global Industry Analysts
... inspiration from time-tested biological sciences available in the natural world and subsequently transfer the technology to a diverse range of disciplines for benefiting humans in improving their health and quality of life. The report analyzes ...  |  read more...
$950.00
7 Things You Need to Know to Profit from Feeder-Free Culture
1/1/2014 | published by: BioInformant Worldwide, L.L.C.
... the topic of feeder-dependent versus feeder-free culture, we completed an end-user survey on this topic. The key findings are synthesized for you in this report, titled "7 Things You Need to Know to Profit from ...  |  read more...
$229.00
Innovative Drug R&D in China (Second Edition) New Developments and Future Prospect
1/1/2014 | published by: JZMed, Inc.
... global drug companies that conduct R&D in China, a healthy R&D environment is being formed in China in the recent years. It has been fostering the growth of a large number of Chinese organizations, including ...  |  read more...
$3,485.00
Covance Inc.: Competitive Benchmarking Report
1/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
$1,799.00
Agilent Technologies, Inc.: Competitive Benchmarking Report
1/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
$1,799.00
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets
1/1/2014 | published by: BCC Research
... reach nearly $8.9 billion by 2018, demonstrating a compound annual growth rate (CAGR) of 18.9% for the five-year period, 2013 to 2018. This report provides: An overview of the global market for cancer diagnostics based ...  |  read more...
$6,650.00
Global Protein Therapeutics Market Outlook 2018
1/1/2014 | published by: RNCOS
... clinical methods to treat a wide spectrum of diseases ranging from cancer to metabolic disorders. The market holds tremendous potential for future growth and it is estimated that by the end of 2018, it may ...  |  read more...
$1,800.00
Analyzing the Biotechnology Industry in India
1/1/2014 | published by: Aruvian's R'search
... the country's biotech industry, the Indian biotechnology market has witnessed remarkable growth in recent years. The biotech industry in India did not bear the brunt of the recent economic recession and in fact due to ...  |  read more...
$500.00
Biotech Business January 2014
1/1/2014 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  read more...
$25.00
Biotech Equipment Update January 2014
1/1/2014 | published by: Worldwide Videotex
Biotech Equipment Update covers news and the latest information about biotechnology lab and manufacturing equipment and products. This includes new product and technology announcements, as well as vendor research, development, and manufacturing information.  |  read more...
$25.00
Mesenchymal Stem Cells
1/1/2014 | published by: Global Industry Analysts
... Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. ...  |  read more...
$4,950.00
China Cord Blood Corporation.: Competitive Benchmarking Report
1/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
$1,799.00
Biotech Financial Reports January 2014
1/1/2014 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  read more...
$25.00
Alkermes Plc - Product Pipeline Review - 2013
12/31/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Alkermes Plc’s corporate ...  |  read more...
$1,500.00
Mitochondrial Diseases - Pipeline Review, H2 2013
12/31/2013 | published by: Global Markets Direct
... for Mitochondrial Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mitochondrial Diseases. Mitochondrial Diseases - Pipeline Review, Half Year ...  |  read more...
$2,000.00
Neuralstem, Inc. - Product Pipeline Review - 2013
12/31/2013 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Neuralstem, Inc.’s corporate ...  |  read more...
$1,500.00
Siena Biotech S.p.A. - Product Pipeline Review - 2013
12/31/2013 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation
12/31/2013 | published by: GBI Research
... biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s performance is significantly superior to other B-cell targeted therapies such as Rituxan (rituximab), which is often used off-license to ...  |  read more...
$3,500.00
BioMarker Strategies, LLC - Product Pipeline Analysis, 2013 Update
12/31/2013 | published by: GlobalData
... solid tumor sample at the point of biopsy. Its SnapPath platform enables the development of PathMap profiles which help guide targeted drug treatment selection, including drug combinations. BioMarker Strategies SnapPath units are being utilized in ...  |  read more...
$750.00
Celltrion, Inc. (068270) - Financial and Strategic SWOT Analysis Review
12/31/2013 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
$125.00
Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review
12/31/2013 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
$125.00
10  11  12  13    15    17  18  19  
 
Our Clients